New Zealand markets closed

Adial Pharmaceuticals, Inc. (ADIL)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.3100-0.0500 (-3.68%)
At close: 04:00PM EDT
1.3400 +0.03 (+2.29%)
After hours: 07:50PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
-
0
0
0
0
Operating expenses
Research development
5,373
-
1,950
8,396
5,853
3,966
Selling general and administrative
9,137
-
8,909
9,345
5,075
4,279
Total operating expenses
14,510
-
10,859
17,740
10,928
8,245
Operating income or loss
-14,510
-
-10,859
-17,740
-10,928
-8,245
Interest expense
-
-
-
-
-
0
Total other income/expenses net
-1,297
-
522
-1,784
2.5
-441.763
Income before tax
-15,790
-
-10,796
-19,517
-10,893
-8,591
Income tax expense
-94.077
-
0
-94.077
0
0
Income from continuing operations
-15,696
-
-10,796
-19,423
-10,893
-8,591
Net income
-15,696
-
-12,731
-19,423
-10,893
-8,591
Net income available to common shareholders
-15,696
-
-12,731
-19,423
-10,893
-8,591
Basic EPS
-5.67
-3.60
-12.71
-26.00
-21.75
-
Diluted EPS
-5.67
-3.60
-12.71
-26.00
-21.75
-
Basic average shares
1,098
1,425
1,002
743.549
498.525
-
Diluted average shares
1,098
1,425
1,002
743.549
498.525
-